Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 6

1.

In vivo near-infrared fluorescence imaging of integrin alphavbeta3 in brain tumor xenografts.

Chen X, Conti PS, Moats RA.

Cancer Res. 2004 Nov 1;64(21):8009-14.

PMID:
15520209
[PubMed - indexed for MEDLINE]
Free Article
2.

Radiolabeled multimeric cyclic RGD peptides as integrin alphavbeta3 targeted radiotracers for tumor imaging.

Liu S.

Mol Pharm. 2006 Sep-Oct;3(5):472-87. Review.

PMID:
17009846
[PubMed - indexed for MEDLINE]
3.

Multimodality tumor imaging targeting integrin alphavbeta3.

Cai W, Sam Gambhir S, Chen X.

Biotechniques. 2005 Dec;39(6 Suppl):S14-25. doi: 10.2144/000112091. Review.

PMID:
20158499
[PubMed - indexed for MEDLINE]
Free Article
4.

RGD-based strategies to target alpha(v) beta(3) integrin in cancer therapy and diagnosis.

Danhier F, Le Breton A, Préat V.

Mol Pharm. 2012 Nov 5;9(11):2961-73. doi: 10.1021/mp3002733. Epub 2012 Oct 4. Review.

PMID:
22967287
[PubMed - indexed for MEDLINE]
5.

Tumor detection and visualization using cyanine fluorochrome-labeled antibodies.

Ballou B, Fisher GW, Hakala TR, Farkas DL.

Biotechnol Prog. 1997 Sep-Oct;13(5):649-58. Review.

PMID:
9336985
[PubMed - indexed for MEDLINE]
6.

Near-infrared optical imaging of proteases in cancer.

Mahmood U, Weissleder R.

Mol Cancer Ther. 2003 May;2(5):489-96. Review.

PMID:
12748311
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk